Browse Clinical trials topic

Health aspects subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Genta to Support Initiation of New Clinical Trial using Ganite[R] as Treatment for Life-Threatening Infections in Patients with Cystic Fibrosis. Dec 2, 2009 1007 Tripep: The ChronVac-C[R] Study Has Been Successfully Completed with Good Safety and Favorable Clinical Data. Nov 27, 2009 691 CytRx to Initiate Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Gastric Cancer. Nov 18, 2009 1118 Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. Nov 16, 2009 696 ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer. Oct 27, 2009 1127 Cytheris Announces Initiation of NIAID/NIH-Sponsored Phase I/IIa Clinical Trial of Interleukin-7 (IL-7). Oct 14, 2009 1687 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection. Oct 7, 2009 904 Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection. Oct 1, 2009 671 Altor BioScience Awarded $3 MM SBIR Bridge Grant by NCI to Advance Clinical Trials for its Targeted Cancer Therapeutic ALT-801. Sep 25, 2009 453 Vaccine trial raises Aids hopes. Sep 24, 2009 520 FAB Pharma, a Biopharma Company Developing Drugs to Treat Severe Bacterial Infections, Raises [euro]2.3 Million in Series A Funding and Begins Recruitment for a Phase I Trial of Its Lead Compound. Sep 12, 2009 431 Statement by Dr. Anthony Fauci, Director, National Institute of Allergy and Infections Diseases, NIH, Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults. Sep 11, 2009 736 Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections. Clinical report Sep 9, 2009 506 Opportunities for advancing dental hygiene research; Periodontitis and premature death: a longitudinal, prospective clinical trial. Soder, Birgitta Clinical report Sep 1, 2009 1131 Alvine Initiates Enrollment in Phase 2a Clinical Trial of ALV003 for Use in the Treatment of Celiac Disease. Clinical report Aug 25, 2009 527 United States : Molecular Insight Pharmaceuticals, Inc. Advances Azedra Program Into Pivotal Phase 2 Therapeutic Trial in Neuroendocrine Cancer Patients. Aug 8, 2009 445 Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia. Jul 28, 2009 725 Clinical studies establish strong link between oral infections and cardiovascular disease. Clinical report Jul 10, 2009 410 Award-Winning Clinical Research Presented at Infusion Nursing Society Conference Demonstrates MaxPlus Clear[TM] Helps Reduce Catheter Related Bloodstream Infections to Zero. Conference news Jun 25, 2009 700 Resolvyx Initiates Phase I Clinical Trial of Novel Resolvin, RX-10001, for Asthma and Inflammatory Diseases. Jun 23, 2009 877 Seattle Genetics Initiates Phase II Trial of SGN-35 for Anaplastic Large Cell Lymphoma. Jun 18, 2009 862 StemCells, Inc. Announces Positive Phase I Batten Trial Results. Jun 8, 2009 2470 Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses in Metastatic Melanoma Patients. Jun 1, 2009 1504 Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer. May 30, 2009 1676 New Clinical Data Shows That Obagi Medical Products' Condition & Enhance System Improves the Results of Intense Pulsed Light Treatments. Clinical report Mar 9, 2009 967 Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections. Feb 17, 2009 764 Cubist Pharmaceuticals Announces Start of First-in-Human Clinical Trial for Investigational New Drug for Clostridium difficile infections. Feb 12, 2009 840 Celsion Commences Pivotal Phase I/II Study of ThermoDox[R] in the Treatment of Recurrent Chest Wall Breast Cancer. Feb 10, 2009 642 Achaogen Initiates Phase 1 Trial of ACHN-490 for Treatment of Multi-Drug Resistant Gram-Negative Bacterial Infections. Feb 3, 2009 554 IRIS International Receives Institutional Review Board Approval to Begin the First Stage of Its Clinical Study Using NADiA[TM] ProsVue[TM] for Identifying Post-Prostatectomy Patients with Low Risk of Prostate Cancer Recurrence. Report Jan 13, 2009 940 NovaBay's NVC-422 Cleared by FDA for Human Clinical Trials in Ophthalmology. Jan 13, 2009 1045 Howard Feldman Joins Bristol-Myers Squibb as Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience. Jan 8, 2009 427 Clinical Data, Inc. Reports Advances in Two Late-Stage Therapeutic Programs. Jan 7, 2009 1372 Resolvyx Announces Initiation of Phase I/II Clinical trial of Novel Resolvin Therapeutic RX-10045 in Patients with Dry Eye. Dec 18, 2008 730 Adipose Stem & Regenerative Cell Clinical Study Underway for Treatment of Chronic Radiation Injury. Clinical report Dec 18, 2008 587 Sarah Cannon Research Institute Sponsors Large-Scale Breast Cancer Trial. Dec 9, 2008 405 InSite Vision Announces Preliminary Results From Phase 3 Clinical Trial of ISV-502 for the Treatment of Eyelid Inflammation and Infection. Dec 8, 2008 1451 Resolvyx Announces Open IND for RX-10045, the Lead Resolvin Therapeutic for Dry Eye. Nov 20, 2008 661 Seven Investigator-Initiated Clinical Studies Announced. Nov 19, 2008 490 Patient Enrollment Begins in Exploratory Phase II Trial of NovaBay's Lead Aganocide Compound, NVC-422, in Catheter-Associated Urinary Tract Infections. Nov 18, 2008 1274 Global Therapeutics Initiates Trial of Next Generation Drug-Eluting Stent Using RNA Therapeutic Agent to Treat Coronary Artery Disease. Nov 10, 2008 800 Optimer Pharmaceuticals Reports Positive Data from its North American Phase 3 CDI Study of OPT-80. Clinical report Nov 10, 2008 1007 Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial. Nov 3, 2008 659 Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B. Nov 1, 2008 2877 Celldex Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF. Oct 31, 2008 1426 Biothera to Present Imprime PGG(R) Clinical Trial Results at the International Society for Biological Therapy of Cancer. Clinical report Oct 30, 2008 459 Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766. Oct 28, 2008 372 Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140. Clinical report Oct 26, 2008 2583 ZymoGenetics Presents Interim IL-21 Phase 2 Results in Renal Cell Cancer. Oct 22, 2008 806 Aethlon Medical Initiates First Clinical Study Of a Medical Device to Treat HIV/AIDS Patients. Sep 29, 2008 1049 Calypso Medical Technologies, Inc., Announces AIM Clinical Study for Prostate Cancer Patients. Clinical report Sep 22, 2008 570 Calypso Medical Announces First Post-Operative Prostatectomy Patient Implanted in Clinical Study to Track Tissue Motion during Radiation Therapy. Clinical report Sep 21, 2008 753 Pluristem Presents Final PLX-PAD Efficacy Data Supporting Upcoming IND Submission to the U.S. FDA. Sep 16, 2008 1155 Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer. Sep 8, 2008 1689 Vertex Pharmaceuticals to Start Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients. Aug 19, 2008 1252 Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe. Aug 5, 2008 747 Optimer Pharmaceuticals Completes Enrollment in OPT-80 Phase 3 Clinical Trial in Patients with Clostridium difficile Infection. Jul 23, 2008 670 Multi-year clinical study data suggest use of FDA-cleared mobile air decontamination unit, PlasmairT2006 with HEPA-MD(TM), contributes to reducing incidence of airborne aspergillosis infection. Clinical report Jul 2, 2008 566 Maximus Features MaxPlus Clear(R) and New Clinical Research at Association for Professionals in Infection Control and Epidemiology Annual Conference June 15-17. Conference news Jun 16, 2008 629 Optimer to Present Additional Data from OPT-80 Phase 2A Study for Clostridium difficile Infection at Anaerobe 2008 Congress. Clinical report Jun 11, 2008 551 Global Clinical Trial Patient Recruitment Best Practices Including Therapeutic Area Approaches, Staff Preparation, Metrics, and Innovations - Tools for Meeting Patient Recruitment Goals - ExL Pharma. Conference news Jun 4, 2008 352 Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Women with Advanced HER2-Negative Breast Cancer. May 31, 2008 1320 VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data. May 30, 2008 869 Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer. May 21, 2008 1042 NovaBay (NBY) Announces Positive Results From Phase IIA Study of AgaNase(TM) For Nasal Decolonization of Staph including MRSA. Report May 19, 2008 1252 NanoViricides' EKC Eye Drug Demonstrates Significant Therapeutic Efficacy in Initial Animal Trials. May 19, 2008 527 KaloBios Initiates Phase 1/2 Trial of Humaneered(TM) Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Mechanically Ventilated Patients. May 19, 2008 443 Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment. Report May 13, 2008 1018 NovaBay's Lead Aganocide Compound, NVC-422, Well Tolerated in the Bladder in Phase I Trial. May 12, 2008 1184 Virostatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection. Clinical report May 12, 2008 633 Anadys Initiates Phase I Clinical Trial of Non-Nucleoside Polymerase Inhibitor for Treatment of Hepatitis C. May 1, 2008 656 Flamel Technologies Presents Results of a Clinical Trial of its Medusa(R) formulation of Interferon Alpha XL at the European Association for the Study of the Liver. Apr 25, 2008 1077 Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B. Apr 24, 2008 2878 Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic. Apr 21, 2008 818 Scott & White Hospital Starts Phase II Clinical Trial. Apr 11, 2008 559 Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection. Apr 9, 2008 1423 Optimer Pharmaceuticals Announces Peer-Reviewed Publication of OPT-80 Phase 1 Clinical Results for the Treatment of Clostridium Difficile Infection. Apr 2, 2008 698 KaloBios Initiates Phase 1/2 Trial of Humaneered(TM) Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Cystic Fibrosis Patients. Mar 31, 2008 556 SIGA Successfully Completes ST-246 Multiple Ascending Dose Human Clinical Trial. Mar 27, 2008 926 ProNAi Therapeutics, Inc. Cleared to Begin Phase I Clinical Trials for the First DNA Interference (DNAi(R)) Therapeutic. Mar 20, 2008 510 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer. Mar 13, 2008 750 Calando Files IND for siRNA Nanoparticle Therapeutic in Oncology. Mar 13, 2008 888 Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients. Clinical report Mar 13, 2008 1345 NovaBay Pharmaceuticals Commences Phase I Human Clinical Trial for the Prevention of Catheter Associated Urinary Tract Infections. Mar 7, 2008 589 Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International's Oxycyte(R). Mar 6, 2008 917 GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy. Mar 3, 2008 1154 Gen-Probe Begins United States Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer. Mar 1, 2008 734 Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers. Feb 27, 2008 1562 Spectrum Pharmaceuticals Receives Approval from Canadian Authorities to Expand EOquin(R) Registrational, Phase 3 Clinical Trials into Canada. Feb 19, 2008 1049 NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA. Jan 22, 2008 931 Progenics Initiates Phase 2 Clinical Trials for PRO 140, a Novel HIV Antibody Therapy. Jan 15, 2008 1444 Nucleonics Initiates Hepatitis B Clinical Trial With Expressed Interfering RNA Therapeutic. Jan 11, 2008 683 Safety Monitoring Committee Recommends That Emergent BioSolutions Continue Its Hepatitis B Immunotherapy Phase II Trial. Medical condition overview Jan 9, 2008 847 NOVABAY REPORTS POSITIVE PHASE I AGANOCIDE RESULTS FOR MRSA. Jan 1, 2008 761 Gene therapy boost for kidney cancer patients; Clatterbridge to be centre for major trials. Dec 24, 2007 440 Altor BioScience Advances Clinical Trial for Targeted Cancer Therapeutic, ALT-801. Dec 20, 2007 484 University Hospitals Researchers Initiate Gene Therapy Trial in Patients with Advanced Skin Cancer. Dec 17, 2007 759 AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic in the Elderly at the American Society of Hematology Annual Meeting. Dec 9, 2007 1125 Can-Fite: IND submission for Phase I Clinical Trials with its Drug for Liver Diseases CF102. Dec 3, 2007 796 Application of standard project management tools to research--a case study from a multi-national clinical trial. Gist, Peter; Langley, David Author abstract Sep 22, 2007 2742